MABLife is a private biotech company founded in 1999, specialising in the development of antibody-based therapeutics for the treatment of cancer, ophthalmic diseases, autoimmune & inflammatory disorders and nosocomial infections. The Company has a focused portfolio of products in development, including one product currently in phase I/II and four at different stages of preclinical development.
Looking for a particular MABLife employee's phone or email?
The MABLife annual revenue was $3.2 million in 2026.
1 people are employed at MABLife.
MABLife is based in Evry, Ile-de-France.
The NAICS codes for MABLife are [3254, 32, 325].
The SIC codes for MABLife are [28, 283].